Neuralink, the brain-computer interface startup co-founded by Elon Musk, has achieved a significant milestone with its experimental brain implant, Blindsight. The U.S. Food and Drug Administration (FDA) granted the device “Breakthrough Device” designation, which accelerates its development and regulatory approval. Blindsight is designed to help restore vision in individuals suffering from complete or partial blindness, including those with damaged optic nerves.
Neuralink took to X (formerly Twitter) to announce the approval and its ambitious goal of restoring sight. “We have received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those who have lost it,” the company shared.
Our Data Prices On JMData:
- MTN SME 1: N255 per 1GB
- MTN SME 2: N259 per 1GB
- Airtel CG: N278 per 1GB
- Glo CG: N230 per 1GB
- 9mobile: N125 per 1GB
Download Our Mobile APP to get started: [JMData] https://play.google.com/store/apps/details?id=com.encrypted.jmdata
PAWS IS THE NEXT $DOGS
This Mining is the next after #DOGS, Don't Miss it Out
Use this link below to Join 👇👇👇👇👇
https://t.me/PAWSOG_bot/PAWS?startapp=6ZSAPFb3
Elon Musk also expressed excitement on his X platform, highlighting the device’s groundbreaking potential to bring vision even to those who have been blind since birth. “Initially, the vision may be low-resolution, comparable to Atari graphics, but it has the potential to improve and even surpass natural sight, enabling users to perceive infrared, ultraviolet, or radar wavelengths,” Musk wrote.
The Blindsight device works by tapping into neural signals in the brain’s visual cortex, bypassing damaged or non-functional optic nerves. This could enable individuals with severe vision impairments to regain visual perception, provided their visual cortex is intact.
Beyond its work on Blindsight, Neuralink is also pioneering brain-computer interfaces aimed at helping paralyzed individuals control devices with their thoughts. The company is currently conducting clinical trials with participants who have spinal cord injuries, testing the effectiveness of its implants in improving quality of life.
Neuralink’s breakthrough comes as part of a broader push to revolutionize treatments for neurological disorders using cutting-edge technology. The FDA’s breakthrough designation signals that the Blindsight device could soon be an integral tool in restoring vision and transforming lives.
JOIN NOW
https://t.me/PAWSOG_bot/PAWS?startapp=6ZSAPFb3
Google News Channel
Follow us on Google News for Latest Headlines
Join Our WhatsApp, Facebook, or Telegram Group For More News, Click This Link Below;
WhatsApp Channel
https://whatsapp.com/channel/0029VaELqhlHVvTXjDnUf80h
WhatsApp Group
https://chat.whatsapp.com/G6Lo3ss6WKLCOqBphZwQGk
Facebook Page
https://facebook.com/allmedia24news
Our Twitter Page
https://www.twitter.com/allmedia24news
Telegram Group
https://www.threads.net/@allmedia24news
Discover more from Allmedia24 News
Subscribe to get the latest posts sent to your email.